Antibodies to Watch in 2022 (On Demand)

Drs. Janice Reichert (The Antibody Society), Alicia Chenoweth (King'sCollege London) and Silvia Crescioli (King'sCollege London) will discuss key events in antibody therapeutics development that occurred in 2021 and forecast events that might occur in 2022. They will provide an update on antibody therapeutics first approved in the US and European Union, as well as the rest of the world, during 2021, and those in regulatory review. Current and potential emergency use authorizations and approvals for anti-SARS-CoV-2 antibodies will also be discussed.

Seminar Information
Date Presented:
December 02, 2021 11:00 AM Eastern
Length:
1 hour
Register Now
In order to access this program after registering, a TAS account will be provided for you based on the information you have entered.

To access your account after your purchase, use the My Account links on the left hand side of this page to login using the information your provide here.
According to our records there is already a TAS account using the email address you have provided.

To continue with your registration please enter your account password. If you do not know your account password you can retrieve it here: Forgot Password?
First Name:
Last Name:
Email:
Confirm Email:
Organization:
Country:
Product:
On-Demand
The email address you have entered has an existing TAS account.

Please enter your password in the field below. Forgot Password?

Email:
Password:
Country:
Billing Address:
City:
State:
State/Province:
Zip:
Expiration: 
Antibodies to Watch in 2022 (On Demand)

Drs. Janice Reichert (The Antibody Society), Alicia Chenoweth (King'sCollege London) and Silvia Crescioli (King'sCollege London) will discuss key events in antibody therapeutics development that occurred in 2021 and forecast events that might occur in 2022. They will provide an update on antibody therapeutics first approved in the US and European Union, as well as the rest of the world, during 2021, and those in regulatory review. Current and potential emergency use authorizations and approvals for anti-SARS-CoV-2 antibodies will also be discussed.

Speaker Information
Alicia Chenoweth  [ view bio ]
Silvia Crescioli  [ view bio ]
Janice Reichert  [ view bio ]
Individual topic purchase: Selected